HIV INFECTIONS IN VACCINE STUDIES

5 June 1994

At least five volunteers in the US government's principal AIDS vaccine study have become infected with HIV, despite receiving the vaccine, through heterosexual intercourse, reports the Marketletter's US correspondent. Researchers are now trying to determine not only how well the vaccine works but also whether vaccination may have increased the likelihood of infection, and in one case even accelerated the progression of the disease.

Four of the five infections have been observed amongst patients who received either the Biocine or Genentech vaccines, which comprise a fragment of outer envelope of the virus. HIV infection has been confirmed in two low-risk volunteers as well as three considered at high risk of contracting the infection. One of the high-risk patients has undergone an unusually rapid decline in circulating CD4 lymphocyte numbers.

While the five case reports have not yet been published in the scientific literature, they have been discussed at scientific progress meetings, including a closed-door session at which it was debated whether or not the US National Institutes of Health should go ahead with plans to test the vaccine in thousands of new, uninfected patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight